Rotavirus vax price inhibits cost effectiveness in Ireland
UK NHS gets NICE advice on medicine adherence
Affordability of Rx drugs similar in Canada and the US
The Australian Government has opened applications for a fourth round of grants for the GP After-Hours Grants Program.
GPs and patients should be more cost aware in UK
The Scottish Government has unveiled its plan to improve cancer survival rates
Australia finalises historic health reforms
It is time we looked at other models for sourcing kidney donors, says Sue Rabbitt Roff from the University of Dundee
A new practice guideline for clinicians who manage patients with chronic obstructive pulmonary disease (COPD) has been issued
Is Cameron's "Big Society" really a smoke screen?
Practice guidelines for the management of autoimmune hepatitis (AIH) have been released
News from IAS
Apixaban most cost effective option in the UK
Drug-eluting stents cost effective vs bare metal stents in Norway
US one of least cost-effective countries in reducing mortality
Liver transplantation appears financially favourable in Finland
Indacaterol the dominant option for COPD in Germany
Prothrombin complex dominates usual care in the ER
Big savings from prevention of nosocomial infections in the ICU
People see value in having Alzheimer's susceptibility revealed
Text-message reminders boost malaria treatment in Kenya
Cost-effective HPV vax strategies in Japan and US
Improving bisphosphonate adherence proves cost effective
Donepezil 23mg has minimal budgetary impact for the US payer
If prevention rates for deep vein thrombosis (DVT) were improved, "considerable savings and reduced morbidity and mortality could be realized",
Prophylaxis upgrades HRQOL in haemophilia A
Down syndrome costs decline with age in Australia
The revenue for regenerative medicine will reach $US8.84 billion in 2021,
The bill which would restrict prescribing via mail-order pharmacies should not be enacted,
Sutent + renal cell carcinoma a winning combination...
NICE rejects fingolimod...
A new report predicts the global vaccine market will reach $US57 billion by 2017.
SMC accepts seven new treatments